The U.S. Justice Department said on Wednesday it has seized over $1.4 billion in COVID-19 relief funds that criminals had stolen, and charged over 3,000 defendants with crimes in federal districts across the country.
After being flagged for safety concerns in July, Apellis has now identified the needle as a possible cause of the cases of severe eye inflammation in patients receiving the company’s recently approved geographic atrophy injection.
AstraZeneca is facing two London lawsuits, including one from the husband of a woman who died after receiving the Anglo-Swedish drugmaker’s COVID-19 vaccine, in the first of potentially dozens of cases brought in England.
Wearable Health Solutions Inc. announced inclusion to Next Realm AI research lab to explore development of healthcare IoT solutions utilizing data analytics and artificial intelligence (AI).
Mallinckrodt said on Wednesday it was planning to file for bankruptcy protection, for a second time in three years as it struggles to pay victims of the opioid crisis, sending the shares of the U.S. drugmaker down 22% in premarket trading.
Novo Nordisk has hired Thermo Fisher as its second contract manufacturer for its hugely popular weight-loss drug Wegovy, a source familiar with the matter told Reuters.
Denmark should stop subsidizing the use of Ozempic and other so-called GLP-1 drugs for patients suffering from type 2 diabetes, and instead pay for cheaper drugs as a preferred first option, a public commission said in a recommendation issued on Tuesday.
The U.S. government said on Tuesday it had awarded $1.4 billion for the development of new therapies and vaccines against COVID-19, including a $326 million contract with Regeneron Pharmaceuticals or a next-generation antibody therapy for prevention of infections.
Teva Pharmaceuticals on Monday announced that it reached a deferred prosecution agreement with the U.S. Department of Justice over its drug price-fixing case involving generic drugs.
3M Co. said on Tuesday that Bryan Hanson would be the chief executive officer of the healthcare company it plans to spin off.